JP7179825B2 - 感知システムを有する薬剤送達デバイス - Google Patents
感知システムを有する薬剤送達デバイス Download PDFInfo
- Publication number
- JP7179825B2 JP7179825B2 JP2020504333A JP2020504333A JP7179825B2 JP 7179825 B2 JP7179825 B2 JP 7179825B2 JP 2020504333 A JP2020504333 A JP 2020504333A JP 2020504333 A JP2020504333 A JP 2020504333A JP 7179825 B2 JP7179825 B2 JP 7179825B2
- Authority
- JP
- Japan
- Prior art keywords
- dose
- sensor
- rotation
- drug delivery
- delivery device
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000012377 drug delivery Methods 0.000 title claims description 101
- 230000033001 locomotion Effects 0.000 claims description 54
- 239000003814 drug Substances 0.000 claims description 44
- 229940079593 drug Drugs 0.000 claims description 22
- 230000004044 response Effects 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 6
- 230000003213 activating effect Effects 0.000 claims 2
- 238000001514 detection method Methods 0.000 description 43
- 238000002347 injection Methods 0.000 description 25
- 239000007924 injection Substances 0.000 description 25
- 230000000875 corresponding effect Effects 0.000 description 18
- 230000004913 activation Effects 0.000 description 8
- 230000008901 benefit Effects 0.000 description 8
- 238000006073 displacement reaction Methods 0.000 description 7
- 230000036961 partial effect Effects 0.000 description 7
- 230000007704 transition Effects 0.000 description 7
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 108010004460 Gastric Inhibitory Polypeptide Proteins 0.000 description 4
- 102100039994 Gastric inhibitory polypeptide Human genes 0.000 description 4
- 238000004891 communication Methods 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 230000005540 biological transmission Effects 0.000 description 3
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000003825 pressing Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 238000003466 welding Methods 0.000 description 3
- 230000009471 action Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000001143 conditioned effect Effects 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000881 depressing effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- PXZWGQLGAKCNKD-DPNMSELWSA-N molport-023-276-326 Chemical class C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(O)=O)[C@@H](C)O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 PXZWGQLGAKCNKD-DPNMSELWSA-N 0.000 description 2
- 229940090048 pen injector Drugs 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 230000001960 triggered effect Effects 0.000 description 2
- 102000051325 Glucagon Human genes 0.000 description 1
- 108060003199 Glucagon Proteins 0.000 description 1
- 229940089838 Glucagon-like peptide 1 receptor agonist Drugs 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108010057186 Insulin Glargine Proteins 0.000 description 1
- 108010065920 Insulin Lispro Proteins 0.000 description 1
- COCFEDIXXNGUNL-RFKWWTKHSA-N Insulin glargine Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H]1CSSC[C@H]2C(=O)N[C@H](C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3C=CC(O)=CC=3)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=3NC=NC=3)NC(=O)[C@H](CO)NC(=O)CNC1=O)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(=O)NCC(O)=O)=O)CSSC[C@@H](C(N2)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)[C@@H](C)CC)[C@@H](C)O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 COCFEDIXXNGUNL-RFKWWTKHSA-N 0.000 description 1
- YSDQQAXHVYUZIW-QCIJIYAXSA-N Liraglutide Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCNC(=O)CC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=C(O)C=C1 YSDQQAXHVYUZIW-QCIJIYAXSA-N 0.000 description 1
- 108010019598 Liraglutide Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- POIUWJQBRNEFGX-XAMSXPGMSA-N cathelicidin Chemical compound C([C@@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O)NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(C)C)C1=CC=CC=C1 POIUWJQBRNEFGX-XAMSXPGMSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 229920002313 fluoropolymer Polymers 0.000 description 1
- 239000004811 fluoropolymer Substances 0.000 description 1
- 229960004666 glucagon Drugs 0.000 description 1
- WNRQPCUGRUFHED-DETKDSODSA-N humalog Chemical compound C([C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CS)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](CO)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CS)NC(=O)[C@H](CS)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@@H](NC(=O)CN)[C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(O)=O)C1=CC=C(O)C=C1.C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CS)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@@H](NC(=O)[C@@H](N)CC=1C=CC=CC=1)C(C)C)C1=CN=CN1 WNRQPCUGRUFHED-DETKDSODSA-N 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 229960002869 insulin glargine Drugs 0.000 description 1
- 229960002068 insulin lispro Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229960002701 liraglutide Drugs 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229940121365 oxyntomodulin analogues Drugs 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
- A61M5/31566—Means improving security or handling thereof
- A61M5/31568—Means keeping track of the total dose administered, e.g. since the cartridge was inserted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/31—Details
- A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
- A61M5/31533—Dosing mechanisms, i.e. setting a dose
- A61M5/31545—Setting modes for dosing
- A61M5/31548—Mechanically operated dose setting member
- A61M5/3155—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe
- A61M5/31551—Mechanically operated dose setting member by rotational movement of dose setting member, e.g. during setting or filling of a syringe including axial movement of dose setting member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/02—General characteristics of the apparatus characterised by a particular materials
- A61M2205/0272—Electro-active or magneto-active materials
- A61M2205/0294—Piezoelectric materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3327—Measuring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3375—Acoustical, e.g. ultrasonic, measuring means
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
Landscapes
- Health & Medical Sciences (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022137273A JP7459194B2 (ja) | 2017-08-21 | 2022-08-30 | 感知システムを有する薬剤送達デバイス |
| JP2024044198A JP7646049B2 (ja) | 2017-08-21 | 2024-03-19 | 感知システムを有する薬剤送達デバイス |
| JP2025034129A JP7758898B2 (ja) | 2017-08-21 | 2025-03-04 | 感知システムを有する薬剤送達デバイス |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762547928P | 2017-08-21 | 2017-08-21 | |
| US62/547,928 | 2017-08-21 | ||
| US201862676576P | 2018-05-25 | 2018-05-25 | |
| US62/676,576 | 2018-05-25 | ||
| PCT/US2018/046585 WO2019040313A1 (en) | 2017-08-21 | 2018-08-14 | DRUG DELIVERY DEVICE HAVING A DETECTION SYSTEM |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022137273A Division JP7459194B2 (ja) | 2017-08-21 | 2022-08-30 | 感知システムを有する薬剤送達デバイス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020528799A JP2020528799A (ja) | 2020-10-01 |
| JP2020528799A5 JP2020528799A5 (enExample) | 2020-11-12 |
| JP7179825B2 true JP7179825B2 (ja) | 2022-11-29 |
Family
ID=63449688
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020504333A Active JP7179825B2 (ja) | 2017-08-21 | 2018-08-14 | 感知システムを有する薬剤送達デバイス |
| JP2022137273A Active JP7459194B2 (ja) | 2017-08-21 | 2022-08-30 | 感知システムを有する薬剤送達デバイス |
| JP2024044198A Active JP7646049B2 (ja) | 2017-08-21 | 2024-03-19 | 感知システムを有する薬剤送達デバイス |
| JP2025034129A Active JP7758898B2 (ja) | 2017-08-21 | 2025-03-04 | 感知システムを有する薬剤送達デバイス |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022137273A Active JP7459194B2 (ja) | 2017-08-21 | 2022-08-30 | 感知システムを有する薬剤送達デバイス |
| JP2024044198A Active JP7646049B2 (ja) | 2017-08-21 | 2024-03-19 | 感知システムを有する薬剤送達デバイス |
| JP2025034129A Active JP7758898B2 (ja) | 2017-08-21 | 2025-03-04 | 感知システムを有する薬剤送達デバイス |
Country Status (12)
| Country | Link |
|---|---|
| US (4) | US11471608B2 (enExample) |
| EP (4) | EP4079350B1 (enExample) |
| JP (4) | JP7179825B2 (enExample) |
| KR (1) | KR102454122B1 (enExample) |
| CN (1) | CN110944698B (enExample) |
| AU (2) | AU2018321269B2 (enExample) |
| CA (1) | CA3073605C (enExample) |
| ES (1) | ES3035589T3 (enExample) |
| IL (1) | IL272781B2 (enExample) |
| MA (1) | MA49946A (enExample) |
| MX (1) | MX2020002012A (enExample) |
| WO (1) | WO2019040313A1 (enExample) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7179825B2 (ja) * | 2017-08-21 | 2022-11-29 | イーライ リリー アンド カンパニー | 感知システムを有する薬剤送達デバイス |
| US11517224B2 (en) | 2017-11-21 | 2022-12-06 | Sanofi | Implantable glucose monitor |
| CN117065149A (zh) | 2017-11-23 | 2023-11-17 | 赛诺菲 | 具有旋转编码器的药剂注射装置 |
| US20200324055A1 (en) * | 2017-12-21 | 2020-10-15 | Sanofi | Apparatus for detecting activation of a drug delivery device |
| EP3836987A1 (en) * | 2018-08-17 | 2021-06-23 | Eli Lilly and Company | Dose detection system for a medication delivery device |
| USD903857S1 (en) | 2018-08-29 | 2020-12-01 | Eli Lilly And Company | Component for a drug delivery device |
| USD903105S1 (en) | 2018-08-29 | 2020-11-24 | Eli Lilly And Company | Component for a drug delivery device |
| USD903858S1 (en) | 2018-08-29 | 2020-12-01 | Eli Lilly And Company | Drug delivery device |
| USD914199S1 (en) | 2018-08-29 | 2021-03-23 | Eli Lilly And Company | Component for a drug delivery device |
| BR112021012996A2 (pt) | 2019-01-04 | 2021-09-14 | Enable Injections, Inc. | Aparelho de injeção de fluido médico e método com emplastro destacável e monitoramento |
| US11109800B2 (en) | 2019-01-04 | 2021-09-07 | Enable Injections, Inc. | Medical fluid injection apparatus and method with detachable patch and monitoring |
| CN117547682A (zh) | 2019-02-27 | 2024-02-13 | 伊莱利利公司 | 具有感测系统的药物输送装置 |
| CA3255868A1 (en) | 2019-08-30 | 2025-06-28 | Lilly Co Eli | METHODS AND APPARATUS FOR DETERMINING A DEVICE DOSE |
| CN110624160B (zh) * | 2019-10-21 | 2020-11-13 | 北京糖护科技有限公司 | 数字化高精度胰岛素笔注射数据采集装置 |
| CN114746136B (zh) * | 2019-11-21 | 2025-05-13 | 赛诺菲 | 药剂递送装置和剂量测量系统 |
| FR3105002B1 (fr) * | 2019-12-19 | 2022-11-25 | Aptar France Sas | Dispositif de distribution de produit fluide |
| CN114901333A (zh) * | 2019-12-27 | 2022-08-12 | 赛诺菲 | 用于检测对注射装置的操纵的设备 |
| US20230125718A1 (en) * | 2020-03-27 | 2023-04-27 | Sanofi | Switch Assembly for an Electronic System of a Drug Delivery Device |
| EP4225406A1 (en) | 2020-03-27 | 2023-08-16 | Sanofi | Drug delivery device with electronic system |
| EP4208221A1 (en) * | 2020-03-27 | 2023-07-12 | Sanofi | Electronic system for a drug delivery device |
| US20230118732A1 (en) * | 2020-03-27 | 2023-04-20 | Sanofi | Electronic System for a Drug Delivery Device |
| EP4126125A1 (en) * | 2020-03-27 | 2023-02-08 | Sanofi | Electronic system for a drug delivery device |
| US20230128892A1 (en) * | 2020-03-27 | 2023-04-27 | Sanofi | Electronic system for a drug delivery device and drug delivery device |
| JP7713472B2 (ja) * | 2020-05-11 | 2025-07-25 | サノフイ | 注射デバイス |
| CN116056741A (zh) * | 2020-07-23 | 2023-05-02 | 赛诺菲 | 用于药物递送装置的电子系统、药物递送装置和相关方法 |
| JP2023540043A (ja) * | 2020-08-26 | 2023-09-21 | イーライ リリー アンド カンパニー | 感知システムを有する薬剤送達デバイス |
| JP2024510586A (ja) * | 2021-03-12 | 2024-03-08 | サノフイ | 注射デバイスの使用をモニタリングするためのデータロギングデバイス |
| WO2023280419A1 (en) * | 2021-07-09 | 2023-01-12 | Sanofi | Data collection apparatus for dose determination |
| WO2023099512A1 (en) | 2021-12-01 | 2023-06-08 | Sanofi | Drug delivery device and dose recording system herewith |
| EP4360674A1 (en) | 2022-10-27 | 2024-05-01 | Ypsomed AG | Automatic injection device with rotation sensor |
| KR102863836B1 (ko) * | 2023-05-26 | 2025-09-25 | (주)집테크놀로지 | 인슐린 투약 관리 장치 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016506845A (ja) | 2013-02-19 | 2016-03-07 | ノボ・ノルデイスク・エー／エス | 用量捕捉モジュールを有する薬剤送達装置 |
| WO2016198516A1 (en) | 2015-06-09 | 2016-12-15 | Sanofi-Aventis Deutschland Gmbh | Data collection apparatus for attachment to an injection device |
| WO2017118705A1 (en) | 2016-01-06 | 2017-07-13 | Sanofi-Aventis Deutschland Gmbh | Medicament delivery device |
Family Cites Families (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5018387B1 (enExample) * | 1968-09-26 | 1975-06-28 | ||
| US5370675A (en) | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
| DK68789A (da) | 1989-02-14 | 1990-08-15 | Novo Nordisk As | Injektionspen |
| CH682805A5 (de) | 1992-02-24 | 1993-11-30 | Medimpex Ets | Anzeigeeinrichtung für ein Injektionsgerät. |
| US5739775A (en) | 1993-07-22 | 1998-04-14 | Bourns, Inc. | Digital input and control device |
| US5536249A (en) | 1994-03-09 | 1996-07-16 | Visionary Medical Products, Inc. | Pen-type injector with a microprocessor and blood characteristic monitor |
| US5676129A (en) | 1996-03-14 | 1997-10-14 | Oneida Research Services, Inc. | Dosage counter for metered dose inhaler (MDI) systems using a miniature pressure sensor |
| JP3677877B2 (ja) | 1996-07-25 | 2005-08-03 | 松下電器産業株式会社 | ゲーム機用エンコーダ |
| US6743202B2 (en) | 1998-06-15 | 2004-06-01 | Medrad, Inc. | Encoding of syringe information |
| US6277099B1 (en) | 1999-08-06 | 2001-08-21 | Becton, Dickinson And Company | Medication delivery pen |
| US6585698B1 (en) | 1999-11-01 | 2003-07-01 | Becton, Dickinson & Company | Electronic medical delivery pen having a multifunction actuator |
| EP1808193A1 (en) | 2001-02-14 | 2007-07-18 | Novo Nordisk A/S | Electronically controlled device |
| US20020120655A1 (en) | 2001-02-26 | 2002-08-29 | Ko-Chien Liu | Pen type step calculating device |
| EP2275158B1 (en) | 2001-05-16 | 2013-01-23 | Eli Lilly and Company | Medication injector apparatus |
| CN100518623C (zh) | 2001-07-09 | 2009-07-29 | 诺沃挪第克公司 | 用于控制两个便携式医疗装置之间数据信息的方法和系统 |
| JP2004313672A (ja) * | 2003-04-10 | 2004-11-11 | Toshihiro Tamano | 麻酔針及びその穿刺クリック感検出装置 |
| KR101121317B1 (ko) | 2003-08-12 | 2012-03-09 | 일라이 릴리 앤드 캄파니 | 기계적 확대율을 갖는 삼중 나사식 쓰레드를 갖는 약제투여 장치 |
| WO2006045523A1 (en) | 2004-10-21 | 2006-05-04 | Novo Nordisk A/S | Medication delivery system with a detector for providing a signal indicative of an amount of an ejected dose of drug |
| WO2006045525A1 (en) | 2004-10-21 | 2006-05-04 | Novo Nordisk A/S | Injection device with a processor for collecting ejection information |
| DE102004063648A1 (de) | 2004-12-31 | 2006-07-20 | Tecpharma Licensing Ag | Injektions- oder Infusionsgerät mit Lebensdauer-Ermittlungseinrichtung |
| EP1999666A1 (en) * | 2006-03-20 | 2008-12-10 | Novo Nordisk A/S | Electronic module for mechanical medication delivery devices |
| US8101091B2 (en) * | 2006-10-02 | 2012-01-24 | Greatbatch Ltd. | Introducer assembly and method for forming an introducer assembly |
| US7989322B2 (en) | 2007-02-07 | 2011-08-02 | Micron Technology, Inc. | Methods of forming transistors |
| EP2060284A1 (en) | 2007-11-13 | 2009-05-20 | F.Hoffmann-La Roche Ag | Medical injection device having data input means and a pivotable display |
| US8187233B2 (en) | 2008-05-02 | 2012-05-29 | Sanofi-Aventis Deutschland Gmbh | Medication delivery device |
| US8790387B2 (en) * | 2008-10-10 | 2014-07-29 | Edwards Lifesciences Corporation | Expandable sheath for introducing an endovascular delivery device into a body |
| JP5562969B2 (ja) | 2008-11-06 | 2014-07-30 | ノボ・ノルデイスク・エー／エス | 電子的に支援された薬剤送達装置 |
| US9724475B2 (en) | 2009-02-27 | 2017-08-08 | Lifescan, Inc. | Drug delivery management systems and methods |
| DK2414003T3 (en) | 2009-03-31 | 2015-08-24 | Sanofi Aventis Deutschland | Device for pharmaceutical feed |
| US8257319B2 (en) | 2009-06-01 | 2012-09-04 | Sanofi-Aventis Deutschland Gmbh | Drug delivery device inner housing having helical spline |
| UA110026C2 (uk) | 2010-03-01 | 2015-11-10 | Пристрій для автоматичного виконання ін'єкції з механізмом затримки, який включає в себе пересувальний елемент подвійного призначення | |
| CN103260675B (zh) | 2010-10-13 | 2016-01-20 | 赛诺菲-安万特德国有限公司 | 剂量设定机构和使用该剂量设定机构的方法 |
| WO2012140097A2 (en) | 2011-04-11 | 2012-10-18 | Novo Nordisk A/S | Injection device incorporating dose monitoring |
| JP2015505253A (ja) | 2011-12-06 | 2015-02-19 | ノボ・ノルデイスク・エー／エス | 注射装置のための駆動機構およびそのような駆動機構を備える注射装置の組み立て方法 |
| CN104220116B (zh) | 2012-02-13 | 2017-10-17 | 赛诺菲-安万特德国有限公司 | 用于附连到注射装置的辅助装置 |
| EP2879740B1 (en) | 2012-08-03 | 2017-03-29 | Sanofi-Aventis Deutschland GmbH | Pen-type drug injection device and electronic add-on monitoring module for monitoring and logging dose setting and administration |
| KR102166894B1 (ko) | 2012-08-31 | 2020-10-16 | 사노피-아벤티스 도이칠란트 게엠베하 | 약물 전달 장치 |
| US20150290396A1 (en) * | 2012-10-23 | 2015-10-15 | Insuline Medical Ltd. | Drug dispensing-tracking device, system and method |
| CN104780959B (zh) | 2012-11-19 | 2017-11-17 | 诺和诺德股份有限公司 | 具有可变剂量设定机构的药物传送装置 |
| KR20140090763A (ko) | 2013-01-10 | 2014-07-18 | 삼성전자주식회사 | 약물 주입기의 주사량 측정 장치 |
| TR201807770T4 (tr) | 2013-01-15 | 2018-06-21 | Sanofi Aventis Deutschland | Kalem tipi ilaç enjeksiyon cihazı ve doz ayarlama ve doz dağıtım modunu ayırt etmek üzere ek sensörlü optik doz değeri kod çözme sistemi. |
| WO2014128155A1 (en) | 2013-02-19 | 2014-08-28 | Novo Nordisk A/S | Dose capturing cartridge module for drug delivery device |
| JP6559072B2 (ja) | 2013-02-19 | 2019-08-14 | ノボ・ノルデイスク・エー／エス | 軸方向スイッチを含む回転センサモジュール |
| ES2799305T3 (es) | 2013-03-15 | 2020-12-16 | Becton Dickinson Co | Adaptador inteligente para dispositivos de infusión |
| US20140276583A1 (en) * | 2013-03-15 | 2014-09-18 | Bayer Healthcare Llc | Injection device with automatic data capture and transmission |
| TW201509471A (zh) | 2013-04-10 | 2015-03-16 | Sanofi Sa | 注射裝置（十一） |
| DK2994180T3 (da) | 2013-05-07 | 2019-12-09 | Sanofi Aventis Deutschland | Hjælpeanordning til fastgøring til en injektionsanordning |
| WO2014180744A1 (en) * | 2013-05-07 | 2014-11-13 | Sanofi-Aventis Deutschland Gmbh | A supplemental device for attachment to an injection device |
| WO2015075136A1 (en) | 2013-11-21 | 2015-05-28 | Novo Nordisk A/S | Rotary sensor assembly with axial switch and redundancy feature |
| WO2015075135A1 (en) | 2013-11-21 | 2015-05-28 | Novo Nordisk A/S | Rotary sensor module with resynchronization feature |
| WO2015075134A1 (en) | 2013-11-21 | 2015-05-28 | Novo Nordisk A/S | Rotary sensor assembly with space efficient design |
| WO2015104022A1 (en) | 2014-01-08 | 2015-07-16 | Bang & Olufsen Medicom A/S | Medical device system and method for establishing wireless communication |
| WO2015138093A2 (en) | 2014-03-12 | 2015-09-17 | Bayer Healthcare Llc | Methods and apparatus for enhancing a medication delivery device |
| EP3659651A3 (en) | 2014-07-10 | 2020-10-14 | Companion Medical, Inc. | Medicine administering system including injection pen and companion device |
| US10799630B2 (en) * | 2014-12-19 | 2020-10-13 | Amgen Inc. | Drug delivery device with proximity sensor |
| EP3045186A1 (en) | 2015-01-16 | 2016-07-20 | Sanofi-Aventis Deutschland GmbH | Sensor for use with a drug delivery device |
| CN107405448B (zh) | 2015-01-23 | 2021-03-23 | 伯克顿迪金森公司 | 用于获取剂量拨号事件的方法和装置 |
| EP3058970A1 (en) | 2015-02-19 | 2016-08-24 | Sanofi-Aventis Deutschland GmbH | Data collection device for attachment to an injection device |
| AU2016238177B2 (en) * | 2015-03-26 | 2021-02-18 | Covidien Lp | Improved acoustical guidance and monitoring system |
| US10792471B2 (en) * | 2015-04-10 | 2020-10-06 | Edwards Lifesciences Corporation | Expandable sheath |
| US20180126088A1 (en) | 2015-05-12 | 2018-05-10 | Novo Nordisk A/S | Rotary Sensor Arrangement for Drug Delivery Device |
| DK3304372T3 (en) | 2015-05-29 | 2019-04-15 | Insulcloud S L | PHARMACEUTICAL MONITORING DEVICE WITH A MEDICINE PEN, WITH LOG, COMMUNICATION AND ALARMS |
| JP6829694B2 (ja) | 2015-06-01 | 2021-02-10 | ノボ・ノルデイスク・エー／エス | 医療用注射装置のためのハウジング |
| JP6893509B2 (ja) * | 2015-07-21 | 2021-06-23 | バイオコープ プロダクション エス．アー．Ｂｉｏｃｏｒｐ Ｐｒｏｄｕｃｔｉｏｎ Ｓ．Ａ． | 注射可能な薬物送達デバイスのための投与量制御システム及び関連の使用方法 |
| EP3162398A1 (en) * | 2015-10-30 | 2017-05-03 | Carebay Europe Ltd. | Medicament delivery device with vibration sensor |
| EP3175876A1 (en) | 2015-12-01 | 2017-06-07 | Carebay Europe Ltd. | Medicament delivery device with user feedback capability |
| EP3178507A1 (en) | 2015-12-09 | 2017-06-14 | Carebay Europe Ltd. | Communication device for transmitting information from a medicament delivery device |
| JP6636794B2 (ja) | 2015-12-24 | 2020-01-29 | 日本電産コパル株式会社 | ステッピングモータ装置 |
| US11083853B2 (en) | 2015-12-28 | 2021-08-10 | Novo Nordisk A/S | Rotary sensor assembly with low-power feature |
| US20170182258A1 (en) * | 2015-12-29 | 2017-06-29 | InsuLog Ltd. | Adjunct device and system for an injector for monitoring injected amounts |
| US11154661B2 (en) | 2016-01-06 | 2021-10-26 | Amgen Inc. | Auto-injector with signaling electronics |
| WO2017148855A1 (en) | 2016-03-01 | 2017-09-08 | Novo Nordisk A/S | Switch arrangement for drug delivery device with data capture |
| EP3216472A1 (en) | 2016-03-11 | 2017-09-13 | Carebay Europe Ltd. | Electrical information device for communicating information related to a medicament delivery |
| US11238150B2 (en) | 2016-05-16 | 2022-02-01 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
| ES2914522T3 (es) | 2016-07-15 | 2022-06-13 | Lilly Co Eli | Módulo de detección de dosis para un dispositivo de administración de medicamentos |
| US9636464B1 (en) | 2016-08-01 | 2017-05-02 | Innovative Precision Instruments Limited | Drug delivery device and a drug information detection device |
| EP3326671A1 (en) | 2016-11-29 | 2018-05-30 | Carebay Europe Ltd. | Activation assembly for a medicament delivery device |
| US11357920B2 (en) | 2016-12-07 | 2022-06-14 | Sanofi | Data collection device for attachment to an injection device |
| BR112019011232B1 (pt) | 2016-12-28 | 2023-12-26 | Genentech, Inc | Haste de bujão de seringa |
| US11383041B2 (en) | 2017-01-25 | 2022-07-12 | Novo Nordisk A/S | Prefilled injection device with cleaning chamber |
| JP7018449B2 (ja) | 2017-02-01 | 2022-02-10 | ノボ・ノルデイスク・エー／エス | 使い捨てペン式薬剤送達装置用およびその内部の回転式用量センシングモジュール |
| US20190022328A1 (en) | 2017-07-21 | 2019-01-24 | Verily Life Sciences Llc | Dosage measurement system in a pen button |
| US20190054251A1 (en) | 2017-08-17 | 2019-02-21 | Qualcomm Incorporated | Medicine delivery device |
| WO2019036576A1 (en) | 2017-08-18 | 2019-02-21 | Eli Lilly And Company | DOSING MEASUREMENT MODULE ON INJECTION PEN |
| JP7179825B2 (ja) * | 2017-08-21 | 2022-11-29 | イーライ リリー アンド カンパニー | 感知システムを有する薬剤送達デバイス |
| WO2019110494A1 (en) | 2017-12-04 | 2019-06-13 | Novo Nordisk A/S | Drug delivery system with multipolar magnet and sensor system |
| CN108030978A (zh) | 2017-12-08 | 2018-05-15 | 福州康为网络技术有限公司 | 一种胰岛素笔采集传输设备 |
| EP3727520B1 (en) | 2017-12-21 | 2024-03-13 | Sanofi | Drug delivery device with non-contact sensor |
| CN108392698B (zh) | 2018-03-14 | 2021-04-09 | 北京大学第三医院（北京大学第三临床医学院） | 一种智能型肌肉精准注射仪 |
| CN112105318B (zh) * | 2018-04-09 | 2024-04-16 | 爱德华兹生命科学公司 | 可扩张护套 |
-
2018
- 2018-08-14 JP JP2020504333A patent/JP7179825B2/ja active Active
- 2018-08-14 IL IL272781A patent/IL272781B2/en unknown
- 2018-08-14 WO PCT/US2018/046585 patent/WO2019040313A1/en not_active Ceased
- 2018-08-14 MA MA049946A patent/MA49946A/fr unknown
- 2018-08-14 EP EP22177763.4A patent/EP4079350B1/en active Active
- 2018-08-14 EP EP22188605.4A patent/EP4101485B1/en active Active
- 2018-08-14 ES ES18762702T patent/ES3035589T3/es active Active
- 2018-08-14 CA CA3073605A patent/CA3073605C/en active Active
- 2018-08-14 CN CN201880054635.6A patent/CN110944698B/zh active Active
- 2018-08-14 AU AU2018321269A patent/AU2018321269B2/en active Active
- 2018-08-14 EP EP18762702.1A patent/EP3672668B1/en active Active
- 2018-08-14 KR KR1020207004685A patent/KR102454122B1/ko active Active
- 2018-08-14 US US16/632,730 patent/US11471608B2/en active Active
- 2018-08-14 MX MX2020002012A patent/MX2020002012A/es unknown
- 2018-08-14 EP EP22189084.1A patent/EP4104884A1/en active Pending
-
2021
- 2021-06-10 AU AU2021203847A patent/AU2021203847B2/en active Active
-
2022
- 2022-06-03 US US17/832,160 patent/US11638785B2/en active Active
- 2022-07-29 US US17/877,114 patent/US12226619B2/en active Active
- 2022-08-04 US US17/880,879 patent/US11771837B2/en active Active
- 2022-08-30 JP JP2022137273A patent/JP7459194B2/ja active Active
-
2024
- 2024-03-19 JP JP2024044198A patent/JP7646049B2/ja active Active
-
2025
- 2025-03-04 JP JP2025034129A patent/JP7758898B2/ja active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2016506845A (ja) | 2013-02-19 | 2016-03-07 | ノボ・ノルデイスク・エー／エス | 用量捕捉モジュールを有する薬剤送達装置 |
| WO2016198516A1 (en) | 2015-06-09 | 2016-12-15 | Sanofi-Aventis Deutschland Gmbh | Data collection apparatus for attachment to an injection device |
| WO2017118705A1 (en) | 2016-01-06 | 2017-07-13 | Sanofi-Aventis Deutschland Gmbh | Medicament delivery device |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7646049B2 (ja) | 感知システムを有する薬剤送達デバイス | |
| JP6932836B2 (ja) | 薬物送達装置のための用量検出モジュール | |
| JP7165783B2 (ja) | 薬物送達装置 | |
| EP4667032A2 (en) | Medication delivery device with sensing system | |
| EA039524B1 (ru) | Устройство для доставки лекарственного препарата с измерительной системой |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200128 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200128 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210217 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210302 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210601 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211102 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220126 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220517 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220830 |
|
| C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20220830 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20220906 |
|
| C21 | Notice of transfer of a case for reconsideration by examiners before appeal proceedings |
Free format text: JAPANESE INTERMEDIATE CODE: C21 Effective date: 20220913 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20221101 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20221116 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 7179825 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |